DE3173310D1 - Pharmaceutical compositions for promoting the healing of wounds - Google Patents

Pharmaceutical compositions for promoting the healing of wounds

Info

Publication number
DE3173310D1
DE3173310D1 DE8181304053T DE3173310T DE3173310D1 DE 3173310 D1 DE3173310 D1 DE 3173310D1 DE 8181304053 T DE8181304053 T DE 8181304053T DE 3173310 T DE3173310 T DE 3173310T DE 3173310 D1 DE3173310 D1 DE 3173310D1
Authority
DE
Germany
Prior art keywords
wounds
healing
promoting
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181304053T
Other languages
English (en)
Inventor
David Cottier
John Knowles Stanley
Richard Frederick Calver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Application granted granted Critical
Publication of DE3173310D1 publication Critical patent/DE3173310D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8181304053T 1980-09-04 1981-09-04 Pharmaceutical compositions for promoting the healing of wounds Expired DE3173310D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8028554 1980-09-04

Publications (1)

Publication Number Publication Date
DE3173310D1 true DE3173310D1 (en) 1986-02-06

Family

ID=10515840

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181304053T Expired DE3173310D1 (en) 1980-09-04 1981-09-04 Pharmaceutical compositions for promoting the healing of wounds

Country Status (15)

Country Link
EP (1) EP0047647B1 (de)
JP (1) JPS5780316A (de)
AU (1) AU7486081A (de)
BE (1) BE890230A (de)
CA (1) CA1198679A (de)
CH (1) CH650148A5 (de)
DE (1) DE3173310D1 (de)
DK (1) DK390181A (de)
ES (1) ES8307491A1 (de)
FI (1) FI812708L (de)
FR (1) FR2489145A1 (de)
GB (1) GB2082911B (de)
IT (1) IT1209894B (de)
NZ (1) NZ198259A (de)
ZA (1) ZA816124B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE82511T1 (de) * 1982-04-22 1992-12-15 Squibb & Sons Inc Granulate zur verwendung bei der behandlung von wunden.
DE3376957D1 (en) * 1982-06-24 1988-07-14 Robert Alan Smith Pharmaceutical gel composition
GR79380B (de) * 1982-09-28 1984-10-22 Johnson & Johnson Prod Inc
EP0137743A3 (de) * 1983-09-13 1986-10-01 Ed. Geistlich Söhne Ag Für Chemische Industrie Topisch anwendbare Arzneimittel
DD248961A1 (de) * 1984-05-22 1987-08-26 Akad Wissenschaften Ddr Verfahren zur herstellung wundheilungsfoerdernder praeparationen
DE3781662T2 (de) * 1986-06-13 1993-03-25 Japan Immund Research Lab Co Wundheilende arzneimittel und kosmetika.
EP0321709A3 (de) * 1987-12-23 1990-04-04 Francisco José Izundegui MacDonnell Schnell heilende und bindende chemische Zusammensetzung oder Heilmittel zur Heilung von verwundeten lebenden tierischen oder menschlichen weichen Geweben, die durch schneidende Kanten oder trennende Kräfte getroffen sind
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
GB2291348B (en) * 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
AU3364297A (en) * 1997-04-02 1998-10-22 Tamaz Shalvovich Mchedlidze Ointments for treating suppurative lesions, burns and trophic ulcers at ll stages, preparation and applications of same
CA2390556C (en) 1999-11-09 2009-05-19 Denki Kagaku Kogyo Kabushiki Kaisha Use of soluble cellulose derivative having been made hardly soluble in water and method for producing it
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
US10413528B2 (en) * 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
JP2020531006A (ja) * 2017-08-18 2020-11-05 カルウッド ニュートリショナルズ，エルエルーシー 筋量および体力を増大させ、肌を処置し、加齢および暴露からの傷みおよび衰えを縮減し、運動および外傷などのストレスからの回復を改善するための組成物および方法
RU2733714C2 (ru) * 2017-11-07 2020-10-06 Общество с ограниченной ответственностью "Трейдсервис" Стабильная комбинированная фармацевтическая композиция диоксидина и анестетиков

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786076A (en) * 1966-10-13 1974-01-15 J Morelle Lipoaminoacids
JPS5233168B2 (de) * 1973-01-08 1977-08-26
FR2215212B1 (de) * 1973-01-18 1976-03-05 Seperic Ch
DE2438703C3 (de) * 1974-08-12 1980-02-21 Ernst Dr.Med. 4970 Bad Oeynhausen Lauven Verwendung einer Mischung bei der Rheumabehandlung
JPS5559106A (en) * 1978-10-27 1980-05-02 Shiseido Co Ltd Oil-in-water type emulsion composition

Also Published As

Publication number Publication date
FI812708L (fi) 1982-03-05
ZA816124B (en) 1982-09-29
IT1209894B (it) 1989-08-30
EP0047647B1 (de) 1985-12-27
ES505172A0 (es) 1983-07-01
JPS5780316A (en) 1982-05-19
NZ198259A (en) 1985-05-31
ES8307491A1 (es) 1983-07-01
GB2082911B (en) 1984-04-18
FR2489145B1 (de) 1984-05-25
IT8149222A0 (it) 1981-09-03
EP0047647A2 (de) 1982-03-17
DK390181A (da) 1982-03-05
EP0047647A3 (en) 1982-09-15
CA1198679A (en) 1985-12-31
GB2082911A (en) 1982-03-17
BE890230A (fr) 1982-01-04
AU7486081A (en) 1982-03-11
FR2489145A1 (fr) 1982-03-05
CH650148A5 (fr) 1985-07-15

Similar Documents

Publication Publication Date Title
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
DE3376957D1 (en) Pharmaceutical gel composition
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
DE3173310D1 (en) Pharmaceutical compositions for promoting the healing of wounds
AU2199283A (en) Pharmaceutical compositions of m-chloro-alpha-t- butylaminopropiophenone
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
GB8327331D0 (en) Application of surgical dressings
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
GB8313814D0 (en) Pharmaceutical compositions
DE3174448D1 (en) Combinations for the treatment of wounds
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
DE3377696D1 (en) Pharmaceutical compositions
GB2124488B (en) Agent for the treatment of wounds
GB2114001B (en) Nasel pharmaceutical compositions
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
ZA837736B (en) Application of surgical dressings
ZA833997B (en) Basic esters exhibiting an antagonistic activity to calcium,process for the preparation thereof and pharmaceutical compositions therefrom
GB8305028D0 (en) Pharmaceutical compositions
PH17582A (en) Pharmaceutical compositions for the treatment of diabetes
IL63593A0 (en) Process for the preparation of new cytostatic compounds and pharmaceutical compositions containing them
GB8312615D0 (en) Compositions for treating infected burn wounds
GB8314736D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee